GCP

Good Clinical Practice (GCP)

In This Article

Related Pages

What Is Good Clinical Practice (GCP)?

Good Clinical Practice (GCP) is an internationally recognized ethical and scientific quality standard for designing, conducting, recording, and reporting clinical trials involving human participants. It ensures the protection of participants’ rights, safety, and well-being, aligning with principles such as those in the Declaration of Helsinki. GCP also ensures the integrity and reliability of trial data, fostering public trust in medical research and regulatory decisions. Compliance is essential for trials supporting drug and treatment approvals globally.

There are a number of recognized standards, regulations, and guidelines governing GCP, the most predominant being ICH E6, which is published by International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (“ICH”). The US FDA’s requirements fall under 21 CFR Part 11, 21 CFR Part 50, 21 CFR Part 54, 21 CFR Part 56, and 21 CFR Part 312, amongst others. 

 

What Is Covered In ICH E6?

The ICH E6(R3) Draft Guideline is an update to the Good Clinical Practice (GCP) standards for clinical trials involving human participants. It emphasizes ethical considerations, participant safety, and data reliability, integrating principles from the Declaration of Helsinki. The guideline is designed to accommodate innovations in trial design and technology, promoting diverse participant inclusion and robust trial outcomes. It outlines roles for investigators, sponsors, and ethics committees, addressing informed consent, quality management, data governance, and risk-based approaches to trial execution and oversight.
 
The objective of this ICH GCP Guideline is to provide a unified standard to facilitate the mutual acceptance of clinical trial data for ICH member countries and regions by applicable regulatory authorities (e.g. FDA, MHRA, TGA, etc).
 

The sections of the ICH E6 (R2) / ICH E6 (R3) Guideline:

  • 1. Institutional Review Board / Independent Ethics Committee
  • 2. Investigator
  • 3. Sponsor
  • 4. Data Governance – Investigator and Sponsor
  • Appendices:
  • —-  A. Investigator’s Brochure
  • —-  B. Clinical Trial Protocols and Protocol Amendments
  • —-  C. Essential Records for the Conduct of a Clinical Trial

 

What Is Covered In 21 CFR Parts 11, 50, 54, etc?

The US FDA’s requirements for GCP are covered by a suite of regulations:
  • 21 CFR Part 11 – Electronic Records; Electronic Signatures – Scope and Application
  • 21 CFR Part 50 – Protection of Human Subjects
  • 21 CFR Part 54 – Financial Disclosure by Clinical Investigators
  • 21 CFR Part 56 – Institutional Review Boards
  • 21 CFR Part 312 – Investigational New Drug Application
 

Who Must Comply with GCP?

Good Clinical Practice (GCP) compliance is required for all parties involved in clinical trials. This includes clinical investigators, sponsors, contract research organizations (CROs), institutional review boards (IRBs), independent ethics committees (IECs), and study personnel. GCP ensures that trials are conducted ethically, the rights and safety of participants are protected, and the data generated is credible and reliable. Compliance is critical for clinical trials intended to support regulatory submissions and approvals worldwide.

Request a Quote

Contact our specialists for a free quote on any of our industry standard services

 

What Type Of Auditing Does GCP Require?

There are a number of different types of audits that can occur to ensure:

  • Pre-study audits: Focus on an organization’s ability to conduct the trial.
  • Mid-study audits: Review the progress of the trial.
  • Post-study audits: Review the data collected.
  • Clinical investigator site audits: Assess compliance with the study protocol, GCP guidelines, and regulatory requirements.
  • Contract research organization audits: Audit CROs for pre-qualification consideration and post-capability CRO study management.
  • Monitoring audits: Focus on the activities of monitors and trial management, including the processes and effectiveness of monitoring participants and results.

Client Testimonials

Quality Auditing provided ARAMARK with excellent service, highly qualified auditors and an exceptional and comprehensive audit report.

Jennifer J. QA Manager

Quality Auditing is responsive and easy to work with, provide timely well-written reports, and make it simple to keep our audit program on track.

Brad S. QA Manager

Friendly auditors are surprisingly hard to find. Maybe that’s because Quality Auditing hired them all?

Michelle L. Supplier Applications Engineer

The ability to eliminate our audit-related travel expenses has been essential in this economic environment.

Sandra P. Quality Engineering Manager

Quality Auditing provided the best auditors I have worked with so far. They are cost effective, knowledgeable, and provide comprehensive audit reports that truly make our organization stronger.

Dave C. Quality Director

Customer Satisfaction Our internal auditor quit and we needed a resource on short notice. Quality Auditing provided us an excellent auditor who was only 25 miles away.

Kurt F. Operations Manager

I’ve worked with a few other companies in the past but Quality Auditing’s reporting style is the best I’ve seen and our auditor really provided us some useful industry insight.

Tom C. Director of Quality

Finally – a company that has the breadth to audit my suppliers all over the US without spending boatloads of money flying people around.

Keith R. Manager of New Product Development

We have been working with Quality Auditing over the past year for supplier audits locally and internationally. They are responsive and easy to work with, provide timely well-written reports, and make it simple to keep our audit program on track.

C. Hokanson